Treanda Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Ibrutinib Combined With Bendamustine and Rituximab in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged > 65 Years
Condition: Mantle Cell Lymphoma (MCL) Intervention: Sponsors: Peking University Third Hospital; Peking Union Medical College Hospital; The Second Affiliated Hospital of Dalian Medical University; Peking University First Hospital; Beijing Tongren Hospital; Beijing Hospital; Beijing Tsinghua Changgeng Hospital; China-Japa n Friendship Hospital; 307 Hospital of PLA; Chinese PLA General Hospital; First Affiliated Hospital of Harbin Medical University; Harbin Medical University; Baotou Cancer Hospital; Beijing Shijitan Hospital, Capital Medical Unive...
Source: ClinicalTrials.gov - June 6, 2022 Category: Research Source Type: clinical trials

Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma
Condition: Relapsed/Refractory Follicular Lymphoma Interventions: Biological: Axicabtagene Ciloleucel; Drug: Cyclophosphamide; Drug: Fludarabine; Drug: Lenalidomide; Drug: Rituximab; Drug: Doxorubicin; Drug: Vincristine; Drug: Prednisone; Drug: Bendamustine Sponsor: Kite, A Gilead Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2022 Category: Research Source Type: clinical trials